Studying heart fat in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial looks at fat stored around the heart in people with type 2 diabetes, using samples already collected from a larger study. Researchers want to understand how this fat relates to diabetes, but it does not test any new drug or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be enrolled in the Angiosafe T2D study and have given permission to use your data and samples.
- You must have signed an extra consent form (called GENTLE) for this specific research.
- You have type 2 diabetes (not type 1 or other rare forms).
- Depending on your age at diagnosis and the amount of fat around your heart, you may fall into one of two groups: diagnosed at or before age 40 with high epicardial fat (over 72 mL), OR diagnosed after age 40 and/or with lower epicardial fat (under 72 mL).
- You cannot be pregnant, nursing, under guardianship, or in prison.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at differences in body fat to understand why some people develop type 2 diabetes. You may be asked for blood tests and health information to see if your diabetes risk and body fat patterns are linked.
This study measures immune cells from your blood to find markers (biomarkers) that may explain or predict diabetic cardiomyopathy, a type of heart condition linked to diabetes. You may benefit mainly by being closely monitored and contributing to research that could improve future diagnosis or risk tracking.
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
This study looks at heart disease risk and how diabetes medications are used in people with type 2 diabetes. It may help doctors better manage your heart health.
This study looks at a specific receptor (CB1) in abdominal fat tissue to understand how it affects fat-related chemicals in the body. Your participation would involve giving consent and having a tissue sample taken during planned internal (visceral) surgery.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.